Allergy Shot Regimen: Choosing Between Conventional, Cluster, and Rush
Four allergy shot regimens exist: conventional (weekly build-up over 24–28 visits, 0.1% systemic reaction per visit per Cox 2011), cluster (2–4 injections/visit, maintenance in 4–8 weeks, ~3× reaction risk per Johns Hopkins), rush (1–3 days, up to 36% reactions without premedication), and ultra-rush (hours, primarily Hymenoptera venom). All share the same 3-to-5-year maintenance phase. Regimen selection depends on patient factors, tolerance, and time-to-maintenance needs.
6 peer-reviewed sources
The four allergy shot regimens are conventional (6-month weekly build-up), cluster (4–8 weeks, higher reaction risk), rush (1–3 days, highest reaction risk), and ultra-rush (hours, venom only). Maintenance phase is the same for all: every 2–4 weeks for 3–5 years.
The essentials
The allergy shot regimen is the clinical protocol selected by the allergist to govern build-up speed, injection frequency, and systemic-reaction risk tradeoff. Four regimens exist in US practice, each targeting a different patient need.
Curex pairs at-home IgE testing with allergist review to identify which allergens and what severity profile would inform regimen selection — the molecular workup that precedes any conventional-vs-cluster-vs-rush decision.
Conventional regimen — the US default per Cox 2011 PP3: one injection per visit, one to two times per week, reaching maintenance in approximately 3–6 months (typically 24–28 weekly visits). Systemic-reaction rate: 0.1% per injection visit per Epstein et al. Year 3 surveillance (PMID 23535092) — the lowest of all regimens. Appropriate for: virtually all aeroallergen patients who can accommodate weekly clinic visits.
Cluster regimen — per Tabar AI et al. (JACI 2005;116:109–118): 2–4 injections per visit, sequentially, at ≥30-minute intervals; reaching maintenance in approximately 4–8 weeks. Pivotal double-blind comparative study with Dermatophagoides pteronyssinus. A clinical-practice series reported that 10.9% of cluster patients experienced a systemic reaction during build-up. A Johns Hopkins analysis found that because cluster patients receive fewer overall injections, the per-injection systemic-reaction risk is "more than 3 fold higher than that of standard immunotherapy" (overall rates 37% cluster vs 21% standard; P=0.084). Appropriate for: aeroallergen patients who cannot commit to 6 months of weekly visits and who are willing to accept higher per-visit monitoring intensity.
Rush regimen — per Cox L. (JACI 2008;122(2), DOI 10.1016/j.jaci.2008.06.007, accelerated schedule review): 1–3 days with multiple injections over hours; reaches or approaches maintenance within days. Highest systemic-reaction risk of aeroallergen schedules: per a classic review (PMID 8977545), reported rates range from "<1% in patients receiving conventional immunotherapy to >36% in patients receiving rush immunotherapy" without premedication. Rush premedication is typically required: antihistamine + corticosteroid ± antileukotriene. A retrospective comparison found maintenance reached at 16.5 weeks (rush) vs 19.3 (cluster) vs 31.1 (standard) — acknowledging that rush patients often complete the final build-up weeks conventionally. Appropriate for: selected aeroallergen patients requiring very rapid desensitization; primarily used at specialist centers.
Ultra-rush regimen — reaches maintenance within hours; primarily used for Hymenoptera venom immunotherapy (VIT). Representative venom studies: a 4-hour bee/wasp ultra-rush reached 111.1-µg maintenance dose in 97.5% of courses, tolerated without hypersensitivity in 82.5% (PMID 16689180); a pediatric modified ultra-rush reached 100-µg maintenance in 24 hours with no systemic reactions (PMID 16724635). Not standard for aeroallergen indications.
Important: all four regimens share the same maintenance phase structure — every 2–4 weeks for 3–5 years per Cox 2011 PP3. Faster build-up does not shorten maintenance.
For eligible aeroallergen patients whose schedule or geography makes any in-clinic regimen impractical, Curex's At-Home Allergy Shot Kit delivers maintenance SCIT at $129/month — the same weekly subcutaneous injection, same USP <797>-compounded personalized serum, same gradual dose-escalation protocol used in clinic, with Zoom-supervised first dose and every dose change, and a prescribed epinephrine auto-injector confirmed on-hand — eliminating the regimen-selection and clinic-logistics trade-off for eligible maintenance patients.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
The build-up timeline differs dramatically across regimens. The maintenance timeline is identical. Understanding this distinction is essential for patients comparing regimen options — faster build-up does not mean faster treatment completion.
Conventional: 1 injection/visit weekly, 24–28 visits. Cluster: 2–4 injections/visit at ≥30-min intervals, 4–8 visits total. Rush: multiple injections over 1–3 days. Ultra-rush: 1 session (venom only). Systemic-reaction risk increases with faster schedules.
Identical across all four regimens per Cox 2011 PP3. Every 2–4 weeks (most US clinics every 3–4 weeks). 30-minute observation mandatory after each injection. Disease-modifying tolerance per Durham 1999 and Jacobsen 2007 accumulates during this shared phase.
Shared endpoint. Per Durham 1999 NEJM: 3–4 years of maintenance produces durable post-treatment remission regardless of which build-up regimen was used.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
What is the difference between conventional, cluster, and rush allergy shots?
The three aeroallergen allergy shot regimens differ only in build-up speed and systemic-reaction risk. Conventional (Cox 2011 PP3 default): one injection per visit, weekly, ~24–28 visits over 6 months to reach maintenance. Systemic-reaction rate 0.1% per visit. Cluster (Tabar 2005): 2–4 injections per visit at ≥30-minute intervals; maintenance in 4–8 weeks; approximately 3× higher per-injection systemic-reaction risk. Rush (Cox 2008): 1–3 days, multiple injections per hour; maintenance in days; up to 36% systemic-reaction rate without premedication. All three then follow the same every-2-to-4-week maintenance phase for 3–5 years. Faster build-up does not shorten the maintenance commitment.
Who is cluster immunotherapy best for?
Cluster immunotherapy per Tabar 2005 is best suited to aeroallergen patients who cannot commit to 6 months of weekly clinic visits but who are willing to accept the higher per-visit systemic-reaction risk (~3× conventional per Johns Hopkins analysis). Practical candidates include: working adults whose job schedules preclude weekly time-off for clinic visits; competitive athletes who need to reach maintenance before a specific competition season; patients with geographic barriers making weekly visits logistically impractical. Relative contraindications to cluster include uncontrolled or unstable asthma (increased systemic-reaction risk) and beta-blocker use (impairs epinephrine rescue if anaphylaxis occurs). Most US allergists perform cluster only in clinic settings with full emergency equipment and a physician present.
How dangerous is rush allergy shot immunotherapy?
Rush immunotherapy carries the highest systemic-reaction risk of any aeroallergen build-up regimen. Per a classic review (PMID 8977545), systemic-reaction rates range from under 1% for conventional to over 36% for rush without premedication. The AAAAI/ACAAI surveillance study (Epstein/Bernstein) documented that cluster and rush immunotherapy were associated with increased risk for systemic reactions versus conventional. Standard practice for aeroallergen rush requires antihistamine plus corticosteroid premedication, close monitoring, and performance in a clinic setting with immediate emergency access. Rush is not appropriate for all patients — uncontrolled asthma, beta-blocker use, and significant cardiovascular disease are contraindications or require careful case-by-case evaluation.
Does choosing a faster regimen mean better results?
No — the efficacy of allergen immunotherapy depends on the maintenance phase dose and duration, not on the build-up speed. Conventional, cluster, and rush regimens all lead to the same maintenance dose (approximately 0.5 mL of maintenance concentrate every 2–4 weeks for 3–5 years) once build-up is complete. The disease-modifying durability per Durham 1999 NEJM is established during maintenance, not build-up. A patient who completed rush in 3 days and then maintained for 4 years has equivalent disease-modifying outcomes to a patient who built up conventionally over 6 months and then maintained for 4 years. The only advantage of faster build-up is faster time to maintenance — not better efficacy.
What is ultra-rush immunotherapy?
Ultra-rush immunotherapy compresses build-up to hours within a single session and is used primarily for Hymenoptera venom immunotherapy (bee, wasp, yellow jacket). Per venom-specific studies, a 4-hour ultra-rush protocol reached the 111.1-µg maintenance dose in 97.5% of courses, with 82.5% tolerating the session without hypersensitivity (PMID 16689180). A pediatric modified ultra-rush reached 100-µg venom maintenance within 24 hours with no systemic reactions (PMID 16724635). Ultra-rush is well tolerated for venom indications because Hymenoptera venom extract formulations have a different reactivity profile than aeroallergen extracts. It is not standard for grass, dust mite, cat, or other aeroallergen indications.
Do all allergy shot regimens require a 30-minute observation period?
Yes — the 30-minute post-injection observation period per Cox 2011 PP3 is mandatory after every injection in every regimen, including conventional, cluster, rush, and ultra-rush. For cluster protocols, where 2–4 injections are given at ≥30-minute intervals within the same visit, the observation period effectively runs concurrently with the inter-injection interval — the 30-minute wait between injections serves as both the observation period for the previous dose and the pre-injection interval for the next. Rush protocols in a day-treatment setting require continuous monitoring throughout the multi-injection session. The 30-minute rule is not relaxed for faster regimens; if anything, closer monitoring is required because per-injection systemic-reaction risk is higher.
Is there a one-time allergy shot that works?
No. SCIT is always a multi-year course — it is never a single injection. "One-time allergy shot" as a query is a misnomer when applied to immunotherapy. There are injections loosely called "allergy shots" that are genuinely one-time: a single corticosteroid depot injection (Kenalog/Depo-Medrol) for seasonal symptom relief, or an emergency epinephrine auto-injector dose. These are NOT immunotherapy — they do not modify the underlying immune response and provide no disease-modifying benefit. Corticosteroid depot injections for routine allergic rhinitis are specifically discouraged by AAAAI/ACAAI practice parameters per Cox 2011 due to side-effect risk.
Related Articles
How Many Allergy Needles? Lifetime Count Guide | Curex
A 5-year SCIT course: ~95 26G–27G injections. Only 43.9% reach maintenance (Tkacz 2021). Curex at-home SCIT at $129/mo — same shots, no clinic visits.
Read moreHow Do Allergy Shots Work? Immune Mechanism | Curex 2025
Allergy shots work through IgG4 blocking antibodies and regulatory T cells. Full science-backed explanation of the molecular cascade behind SCIT.
Read moreAllergy Shots Timeline: 3-Phase Patient Journey | Curex
Allergy shots timeline in 3 phases: build-up (6 months weekly), maintenance (3–5 years monthly), post-treatment remission (7–10 years). Phase-by-phase patient narrative.
Read moreTypes of Allergy Injections: Full Guide | Curex
Types of allergy injections include SCIT (immunotherapy), biologics like Xolair and Dupixent, depot steroids, and epinephrine. Only SCIT modifies the underlying disease.
Read moreAllergy Shots Ingredients FAQ: Mercury, Blood, Latex | Curex
Is there mercury in allergy shots? Blood? Latex? mRNA? Each concern answered with citations. Modern US shots use phenol 0.4% and glycerin, not thimerosal.
Read moreAllergy Shot For Humans: SCIT & SLIT Guide
Yes, there is an allergy shot for humans — subcutaneous immunotherapy (SCIT). Cochrane SMD −0.73, 3–5 yr course, at home via Curex $129/mo. Not Cytopoint.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.